0000950170-24-011475.txt : 20240205
0000950170-24-011475.hdr.sgml : 20240205
20240205201612
ACCESSION NUMBER: 0000950170-24-011475
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240201
FILED AS OF DATE: 20240205
DATE AS OF CHANGE: 20240205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PALEKAR ROHAN
CENTRAL INDEX KEY: 0001423327
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39122
FILM NUMBER: 24597736
MAIL ADDRESS:
STREET 1: 201 SPEAR STREET, THIRD FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: 89bio, Inc.
CENTRAL INDEX KEY: 0001785173
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 831114349
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 142 SANSOME STREET
STREET 2: SECOND FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: (415) 432-9270
MAIL ADDRESS:
STREET 1: 142 SANSOME STREET
STREET 2: SECOND FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
4
1
ownership.xml
4
X0508
4
2024-02-01
0001785173
89bio, Inc.
ETNB
0001423327
PALEKAR ROHAN
C/O 89BIO, INC.
142 SANSOME STREET, 2ND FLOOR
SAN FRANCISCO
CA
94104
true
true
false
false
Chief Executive Officer
false
Common Stock
2024-02-01
4
A
false
150000
0.00
A
498714
D
Common Stock
2024-02-05
4
F
false
5068
9.80
D
493646
D
Stock Option (Right to Buy)
9.98
2024-02-01
4
A
false
605000
0
A
2034-02-01
Common Stock
605000
605000
D
Represents restricted stock units ("RSUs") that vest in equal semi-annual installments over three years, subject to the Reporting Person's continued service to the Issuer.
These shares were withheld from the vesting of a performance-based RSU award to cover the estimated tax withholding obligation.
This option represents a right to purchase a total of 605,000 shares of the Issuer's Common Stock, one quarter of which will vest on February 1, 2025, with the remaining three quarters vesting in equal quarterly installments over the following three years, subject to the Reporting Person's continued service to the Issuer.
/s/ Ryan A. Murr, as attorney-in-fact for Rohan Palekar
2024-02-05